Sutkin Gary, Lowder Jerry L, Smith Kenneth J
Division of Urogynecology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh-School of Medicine, 300 Halket Street, Pittsburgh, PA 15213, USA.
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Aug;20(8):933-8. doi: 10.1007/s00192-009-0885-y. Epub 2009 Apr 10.
The objective of this study is to estimate efficacy of prophylactic antibiotics in UTI prevention during CISC for postoperative voiding dysfunction after prolapse/incontinence surgery.
We constructed a decision tree model to evaluate risks and benefits of prophylactic antibiotics during CISC for voiding dysfunction after prolapse/incontinence surgery. The model randomized women requiring CISC to prophylactic antibiotics or no prophylaxis. Probabilities for UTI after CISC with or without prophylactic antibiotics, sequelae from antibiotic use or UTI, and utility values were obtained from published literature and practice quality assurance reviews. Main outcome was probability of experiencing no UTI or adverse event.
Under baseline assumptions, prophylactic antibiotics were favored in both models. In the true UTI model, prophylactic antibiotics had an 83.1% probability of no UTI or adverse events; 16.1% better than no prophylactic antibiotics.
Using decision analysis methods, prophylactic antibiotics are favored for prevention of UTI during CISC to manage voiding dysfunction after prolapse/incontinence surgery.
本研究的目的是评估间歇性清洁导尿(CISC)期间预防性使用抗生素对盆腔器官脱垂/尿失禁手术后排尿功能障碍患者预防尿路感染(UTI)的疗效。
我们构建了一个决策树模型,以评估盆腔器官脱垂/尿失禁手术后排尿功能障碍患者在CISC期间预防性使用抗生素的风险和益处。该模型将需要CISC的女性随机分为预防性使用抗生素组或不进行预防组。使用或不使用预防性抗生素进行CISC后发生UTI的概率、抗生素使用或UTI的后遗症以及效用值均来自已发表的文献和实践质量保证评估。主要结局是未发生UTI或不良事件的概率。
在基线假设下,两种模型均支持预防性使用抗生素。在真实UTI模型中,预防性使用抗生素无UTI或不良事件的概率为83.1%;比不使用预防性抗生素高16.1%。
使用决策分析方法,预防性使用抗生素有利于在盆腔器官脱垂/尿失禁手术后CISC管理排尿功能障碍期间预防UTI。